Metabolism-related enzyme alterations identified by proteomic analysis in human renal cell carcinoma

Por Lu, Zejun, Yao, Yuqin, Song, Qi, Yang, Jinliang, Zhao, Xiangfei, Yang, Ping, Kang, Jingbo
Publicado no Onco Targets Ther (2016)

Discovery of human lactate dehydrogenase A (LDHA) inhibitors as anticancer agents to inhibit the proliferation of MG-63 osteosarcoma cells

Por Fang, Aiping, Zhang, Qi, Fan, Haibo, Zhou, Yaying, Yao, Yuqin, Zhang, Yue, Huang, Xiaojun
Publicado no Medchemcomm (2017)

Establishment and characterization of intraperitoneal xenograft models by co-injection of human tumor cells and extracellular matrix gel

Por YAO, YUQIN, ZHOU, YONGJUN, SU, XIAOLAN, DAI, LEI, YU, LIN, DENG, HONGXIN, GOU, LANTU, YANG, JINLIANG
Publicado no Oncol Lett (2015)

Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)

Por Tang, Sumin, Yin, Yuan, Shen, Chaoyong, Chen, Jiaju, Yin, Xiaonan, Zhang, Bo, Yao, Yuqin, Yang, Jinliang, Chen, Zhixin
Publicado no World J Surg Oncol (2017)

Multi‐technical analysis on the antioxidative capacity and total phenol contents of 94 traditional Chinese dietary medicinal herbs

Por He, Fangting, Chen, Jiayi, Dong, Ke, Leng, Yun, Xu, Jiayi, Hu, Pengwei, Yao, Yuqin, Xiong, Jingyuan, Pei, Xiaofang
Publicado no Food Sci Nutr (2018)

High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma

Por Zhou, Shijie, Wang, Ping, Su, Xiaolan, Chen, Jingxia, Chen, Hongfen, Yang, Hanbing, Fang, Aiping, Xie, Linshen, Yao, Yuqin, Yang, Jinliang
Publicado no PLoS One (2017)

Correction: High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma

Por Zhou, Shijie, Wang, Ping, Su, Xiaolan, Chen, Jingxia, Chen, Hongfen, Yang, Hanbing, Fang, Aiping, Xie, Linshen, Yao, Yuqin, Yang, Jinliang
Publicado no PLoS One (2018)

Promiximab-duocarmycin, a new CD56 antibody-drug conjugates, is highly efficacious in small cell lung cancer xenograft models

Por Yu, Lin, Lu, Ying, Yao, Yuqin, Liu, Yu, Wang, Yuxi, Lai, Qinhuai, Zhang, Ruirui, Li, Wenting, Wang, Ruixue, Fu, Yuyin, Tao, Yiran, Yi, Shuli, Gou, Lantu, Chen, Ligong, Yang, Jinliang
Publicado no Oncotarget (2017)

Therapeutic potential of an anti-HER2 single chain antibody–DM1 conjugates for the treatment of HER2-positive cancer

Por Zhang, Hang, Wang, Yuxi, Wu, Yangping, Jiang, Xiaohua, Tao, Yiran, Yao, Yuqin, Peng, Yujia, Chen, Xiangzheng, Fu, Yuyin, Yu, Lin, Wang, Ruixue, Lai, Qinhuai, Lai, Weirong, Li, Wenting, Kang, Yuhuan, Yi, Shuli, Lu, Ying, Gou, Lantu, Wu, Min, Yang, Jinliang
Publicado no Signal Transduct Target Ther (2017)

A novel 5T4-targeting antibody-drug conjugate H6-DM4 exhibits potent therapeutic efficacy in gastrointestinal tumor xenograft models

Por Wang, Ruixue, Lai, Qinhuai, Tang, Liangze, Tao, Yiran, Yao, Yuqin, Liu, Yu, Lu, Ying, Shen, Chaoyong, Lu, Ran, Fan, Chuanwen, Zhang, Ruirui, Wang, Yuxi, Yu, Lin, Yang, Tinghan, Wu, Yangping, Peng, Yujia, Wei, Xian, Fu, Yuyin, Lai, Weirong, Gou, Lantu, Yang, Jinliang
Publicado no Am J Cancer Res (2018)